Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764269 · ClinicalTrials.gov registry record · NA
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 656
- Enrollment target
NCT01764269 is a NA study that has completed, run by Columbia University. The registered enrollment target is 656 participants.
The verdict
NCT01764269, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 656 participants
- Enrollment target
Study Summary
In this study, the investigators will prospectively assess fever rates in 24-59 month old patients during days 0-10 after administration of inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV). Children in one of three study sites who receive these vaccines as part of their routine care can enroll in this study if their parent has the ability to receive and send text messages. Children enrolled in this study will be observed for an eleven day period starting on the day of vaccine administration via a series text messages to their parents.
Interventions
- OTHER text message surveillance for fever
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 656 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01764269
The ClinicalTrials.gov registry entry for NCT01764269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 656 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which text message surveillance for fever is the first listed.
NCT01764269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01764269 about?
NCT01764269 is a clinical study titled "Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014". In this study, the investigators will prospectively assess fever rates in 24-59 month old patients during days 0-10 after administration of inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV). Children in one of three study sites who receive these vaccines as part of thei...
What is the current status of trial NCT01764269?
This trial is currently completed. It is a NA study. The enrollment target is 656 participants. The study started on 2013-01. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01764269?
The interventions under investigation include: text message surveillance for fever (OTHER).
Who is sponsoring clinical trial NCT01764269?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.